Biocracked
←

#fda

1 article
Approach 4, conceptual metaphor, in palette D, bold color field.

A single frayed shoelace-style aglet stands in for a telomere cap: a glossy brass-tipped cord end, photographed in tight macro, its braided fibers splitting apart and unraveling at the worn end. The cord is cream white and the brass tip catches a crisp highlight. It rests on a seamless saturated mustard-yellow backdrop. The camera sits at a low three-quarter angle, with the frayed end sharp in the foreground and the rest of the cord falling softly out of focus to the right. Hard, directional studio light from the upper left casts a clean, short shadow on the yellow surface. A thin electric green thread runs through the braid, the only trace of green in the frame. Mood: skeptical, scrutinizing, a promise that doesn't hold together. No text anywhere.
peptides

Epitalon: The Telomere Peptide Everyone's Injecting Is Unproven

BY NOVA CHEN ·

Epitalon is pitched online as the telomere peptide that could slow aging, but a new 2026 review says the evidence tells a different story. Human data are limited to small biomarker studies and one older retinitis pigmentosa trial, with no adequately powered randomized trial showing efficacy. Dosing, pharmacokinetics, and long-term safety remain unvalidated, and questions about cancer risk, immunogenicity, product quality, and FDA scrutiny are still open. Here's what the science supports, what it doesn't, and who should steer clear.

This page is available in